Subscribe to Journal
Get full journal access for 1 year
We are sorry, but there is no personal subscription option available for your country.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Ballen KK, Becker PS, Emmons RVB, Fitzgerald TJ, Hsieh CC, Liu Q et al. Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancy. Blood 2002; 100: 442–450.
Colvin GA, Berz D, Ramanathan M, Winer ES, Fast L, Elfenbein GJ et al. Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism. Biol Blood Marrow Transplant 2009; 15: 421–431.
Guo M, Hu K-X, Yu C-L, Sun Q-Y, Qiao J-H, Wang D-H et al. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients. Blood 2011; 117: 936–941.
Guo M, Hu K-X, Liu G-X, Yu C-L, Qiao J-H, Sun Q-Y et al. HLA-mismatched stem-cell microtransplantation as postremission therapy for acute myeloid leukemia: long-term follow-up. J Clin Oncol 2012; 30: 4084–4090.
Grupp SA, Porter DL, Teachey DT, Barrett DM, Chew A, Suppa E et al. CD19-redirected chimeric antigen receptor T (CART19) cells induce a cytokine release syndrome (CRS) and induction of treatable macrophage activation syndrome (MAS) that can be managed by the IL-6 antagonist Tocilizumab (toc). ASH Annu Meet Abstr 2012; 120: 2604.
Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ et al. Cellular immunotherapy for refractory hematological malignancies. J Transl Med 2013; 11: 150.
Rubio MT, Kim YM, Sachs T, Mapara M, Zhao G, Sykes M . Antitumor effect of donor marrow graft rejection induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: critical role for recipient-derived IFN-gamma. Blood 2003; 102: 2300–2307.
Rubio MT, Saito TI, Kattleman K, Zhao G, Buchli J, Sykes M . Mechanisms of the antitumor responses and host-versus-graft reactions induced by recipient leukocyte infusions in mixed chimeras prepared with nonmyeloablative conditioning: a critical role for recipient CD4+ T cells and recipient leukocyte infusion-derived IFN-gamma-producing CD8+ T cells. J Immunol 2005; 175: 665–676.
Saito TI, Li HW, Sykes M . Invariant NKT cells are required for antitumor responses induced by host-versus-graft responses. J Immunol 2010; 185: 2099–2105.
Symons HJ, Levy MY, Wang J, Zhou X, Zhou G, Cohen SE et al. The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells. Biol Blood Marrow Transplant 2008; 14: 499–509.
The symposium and publication of this supplement were sponsored by the Division of Hematology/Oncology at the Warren Alpert Medical School of Brown University and NIH Center of Biomedical Research Excellence (COBRE) for Stem Cells Biology at Rhode Island Hospital.
The author declares no conflict of interest.
About this article
Cite this article
Reagan, J. Adoptive immunotherapy for myeloid malignancies. Leukemia Suppl 3, S21–S22 (2014). https://doi.org/10.1038/leusup.2014.12
- halpoidentical peripheral blood stem cells
- minimal conditioning
- cytokine release syndrome
- cellular infusion